Inventor · disambiguated record
Steven Chappell Mitchell
Also filed as: MITCHELL STEVEN C · MITCHELL STEVEN CHAPPELL
11 granted patents·3 pending applications·95 citations·filing 2002–2007
90Inventor score
Top patents by PatentIndex Score
14 records- 0189US7575749B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2004·Granted Aug 18, 2009·18 cites·3 claims
- 0286US7455991B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2004·Granted Nov 25, 2008·14 cites·6 claims
- 0385US7947459B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2004·Granted May 24, 2011·19 cites·11 claims
- 0483US8241626B2Serpentine transmembrane antigens expressed in human cancers and uses thereofHUBERT RENE S·Filed 2006·Granted Aug 14, 2012·7 cites·11 claims
- 0577US7319006B2Serpentine transmembrane antigens expressed in human cancers and uses thereofGENENTECH INC·Filed 2004·Granted Jan 15, 2008·20 cites·13 claims
- 0674US7892548B2121P1F1: a tissue specific protein highly expressed in various cancersAGENSYS INC·Filed 2007·Granted Feb 22, 2011·0 cites·10 claims
- 0772US7727533B2Serpentine transmembrane antigens expressed in human cancers and uses thereofGENENTECH INC·Filed 2004·Granted Jun 1, 2010·15 cites·3 claims
- 0871US7351583B2Antibodies to G protein-coupled receptorAGENSYS INC·Filed 2004·Granted Apr 1, 2008·1 cites·10 claims
- 0967US2005074807A1Novel gene upregulated in cancers of the prostateAGENSYS INC·Filed 2004·Application pending·0 cites
- 1060US7582448B284P2A9: a prostate and testis specific protein highly expressed in prostate cancerAGENSYS INC·Filed 2006·Granted Sep 1, 2009·0 cites·10 claims
- 1159US7309585B2121P1F1: a tissue specific protein highly expressed in various cancersAGENSYS INC·Filed 2005·Granted Dec 18, 2007·0 cites·14 claims
- 1258US7569356B2Diagnosis and therapy of cancer using SGP28-related moleculesAGENSYS INC·Filed 2004·Granted Aug 4, 2009·1 cites·12 claims
- 1352US2005214211A1Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancerCHALLITA-EID PIA M·Filed 2005·Application pending·0 cites
- 1449US2003149531A1Serpentine transmembrane antigens expressed in human cancers and uses thereofFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven Chappell Mitchell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →